Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.648 USD | +1.30% | -0.32% | -13.09% |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.09% | 13.49M | |
+42.60% | 54.04B | |
+43.57% | 41.96B | |
-1.46% | 41.92B | |
-7.59% | 28.35B | |
+11.59% | 26.35B | |
-21.99% | 19B | |
+7.71% | 13B | |
+28.74% | 12.28B | |
+25.68% | 12.19B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Onconova Therapeutics Doses First Patient in Clinical Trial of Endometrial Cancer Combination Therapy